Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19637893 | 0.98 | KDM4E (0.33) | KDM4EATML3MBTL1 | |
| SCHEMBL15806128 | 0.98 | KDM4E (0.33) | KDM4EATML3MBTL1 | |
| SCHEMBL17904158 | 0.97 | KDM4E (0.33) | KDM4EATML3MBTL1 | |
| SCHEMBL20077945 | 0.96 | KDM4E (0.32) | KDM4EATML3MBTL1 | |
| SCHEMBL16978556 | 0.96 | KDM4E (0.35) | KDM4EATML3MBTL1 | |
| SCHEMBL15806102 | 0.96 | KDM4E (0.35) | KDM4EATML3MBTL1 | |
| SCHEMBL15832139 | 0.96 | KDM4E (0.35) | KDM4EATML3MBTL1 | |
| SCHEMBL17904180 | 0.95 | KDM4E (0.34) | KDM4EATML3MBTL1ALDH1A1MAPT | |
| SCHEMBL802759 | 0.93 | MAPT (0.31) | KDM4EL3MBTL1ALDH1A1MAPTMAPK1 | |
| SCHEMBL17904194 | 0.93 | KDM4E (0.32) | KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9985220-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2018-05-29 | — | — | US | disclosed |
| US-9985220-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2018-05-29 | — | — | US | disclosed |
| EP-2931698-B1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2017-09-13 | — | — | EP | disclosed |
| US-20150333274-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2015-11-19 | — | — | US | disclosed |
| US-20150333274-A1 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2015-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150333274-A1 | MATERIALS FOR ELECTRONIC DEVICES | CYP2C19, CYP2C9, ECI1 | KDM4E 2396/4885ATM 3302/4885L3MBTL1 3495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.